Afasevikumab

Tax included
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities.
MedChemExpress 
HY-P99424

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
CAS
1589503-30-9